A person receives a fourth dose of the Pfizer-BioNTech COVID-19 coronavirus vaccine at Ichilov Tel Aviv Sourasky Medical Centre in Israel’s Mediterranean coastal city of Tel Aviv on Jan. 3, 2022. Israel’s prime minister says a 4th vaccination against the omicron variant of the coronavirus generates a five-fold increase in antibodies to fight the virus. Naftali Bennett said on Jan. 4 that an early study at Sheba Medical Center offered encouraging results just a week after a 4th jab was offered to vulnerable people.
JACK GUEZ, AFP via Getty Images

As the highly transmissible omicron variant replaces delta as the dominant strain of the coronavirus, another new variant has sparked some interest but current data indicates it’s not a cause for concern.

The variant, called B.1.640.2, was dubbed the “IHU variant” by researchers at the Méditerranée Infection University Hospital Institute (IHU) in Marseilles, who first identified the variant in France in November, according to Forbes magazine.

According to a December study that is not yet peer-reviewed, the researchers confirmed 12 patients tested positive for the variant, which contained mutations that also appeared in other fast-spreading variants.

While the new variant was discovered about the same time as omicron, the B.1.640.2 variant hasn’t been detected anywhere outside the southern Alps region of France, TIME magazine reported.

Where do variants come from?:Scientists suggest the omicron variant evolved in one person

How omicron is shaping the pandemic:US coronavirus cases surge past previous records

The World Health Organization says the B.1.640.2 variant “has been on our radar,” but it’s not considered a variant of interest or concern. 

“That virus had a lot of chances to pick up,” said Abdi Mahamud, incident manager for the WHO’s COVID-19 Incident Management Support Team, at a news briefing in Geneva Tuesday.

What is the new 'IHU' variant discovered in France? - YouTube

“I would expect additional variants to arise that are related to omicron in some ways but different in others,” Julie Swann, professor at North Carolina State University who studies pandemic modeling and health systems. “It remains to be seen what that would mean for real-world spread.”

Like Our Story ? Donate to Support Us, Click Here

You want to share a story with us? Do you want to advertise with us? Do you need publicity/live coverage for product, service, or event? Contact us on WhatsApp +16477721660 or email Adebaconnector@gmail.com

Leave a Reply

Your email address will not be published. Required fields are marked *